D4 Diagnostics has developed D4BST to quantify the number of immune cells in tumors prior to treatment. D4BST is an assay for accurate, fast and reliable quantification of B-, Switched B- and T cells in traces of DNA from tumors or its surrounding environment.

Assisting people to make diet-related lifestyle changes through gaming

A new class of dual drugs for cancer treatment which are well tolerated and can be taken orally

EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Encytos has developed a micro(nano)structured (topographic) inorganic substrate for spheroid and organoid cell growth.

Simple blood tests to detect cancer

Opposed to the current heparin production method, our technology has the potential to ensure supply security, reduce risk of contamination and remove dependency on animal material.

Optimal delivery to ensure effective treatment of cancer and more

With Fybrix, we offer a synthetic, customizable and animal-free 3D cell culture material that uniquely mimics the native cell environment, in contrast to other synthetic materials that have been introduced in the market.